Bristol Myers Squibb stock last at USD 61.93, up 0.71 percent in New York trading
Published on 09/25/2026 at 18:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Bristol Myers Squibb stock was last at USD 61.93 on the NYSE on September 25, 2026, up USD 0.43 or 0.71 percent at 12:34 p.m. ET. The stock was ahead of the SPY ETF, which was up 0.47 percent at the same time. Bristol Myers Squibb's October 2, 2026 record date for its USD 0.63 dividend is the next dated shareholder event.
The session on September 25, 2026 in figures
Bristol-Myers Squibb Company (ISIN US1101221083, NYSE: BMY) opened at USD 61.75 on September 25, 2026, according to NYSE quote data at 12:34 p.m. ET. The stock reached an intraday high of USD 62.28 and an intraday low of USD 61.39 during that session. The latest level of USD 61.93 stood USD 0.44 above the prior-session reference of USD 61.49.
The session moved from the USD 61.75 opening level to the USD 62.28 high before retreating to USD 61.39 and recovering to USD 61.93. Trading volume reached 3,974,531 shares at 12:34 p.m. ET. The stock was 9.78 percent below its 52-week high of USD 68.64 and 45.65 percent above its 52-week low of USD 42.52.
Analyst upgrade and dividend date shape the background
The Zacks Research rating change gave Bristol Myers Squibb a company-specific headline on September 25, 2026. As MarketBeat reported, Zacks Research upgraded the shares from hold to strong buy.
Bristol Myers Squibb's dividend record date of October 2, 2026 followed the board's declaration of a USD 0.63 quarterly payment. As Business Wire reported on September 16, 2026, the payment is scheduled for November 2, 2026. The dividend record date places the shareholder cutoff within the next five trading sessions.
Oil prices and Treasury yields shaped the September 25, 2026 market backdrop. As Investopedia reported, oil prices and Treasury yields eased after influencing the prior session, while major index futures pointed higher. The combination left defensive healthcare shares mixed during the New York session.
Healthcare peers and market comparison on September 25, 2026
The SPY ETF was at USD 770.76, up USD 3.58 or 0.47 percent at 12:34 p.m. ET. Bristol Myers Squibb's 0.71 percent gain exceeded that market proxy by 0.24 percentage points. Pfizer was at USD 28.32, down 0.33 percent, while Merck was at USD 147.72, down 0.18 percent, and Eli Lilly was at USD 1,162.92, down 1.61 percent. Bristol Myers Squibb's volume stood at 3,974,531 shares, compared with 16,908,418 shares for the SPY ETF at the same time.
Dividend record date on October 2, 2026
The October 2, 2026 record date determines eligibility for Bristol Myers Squibb's USD 0.63 quarterly dividend. The November 2, 2026 payment date follows the record date by one month. Bristol Myers Squibb's third-quarter 2026 results are scheduled for October 29, 2026, with the conference call set for 8:00 a.m. ET.
